Benzinga | Aug 10, 2020 04:55PM EDT

Catalyst Pharmaceuticals Q2 EPS $0.09 Beats $0.08 Estimate, Sales $29.60M Beat $29.48M Estimate

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.08 by 12.5 percent. This is a 10 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $29.60 million which beat the analyst consensus estimate of $29.48 million by 0.41 percent. This is a 2.64 percent increase over sales of $28.84 million the same period last year.